Recent Quotes (30 days)

You have no recent quotes
chg | %

Market summary

12:17PM EDT

World markets

Shanghai 2,979.34 -14.98 (-0.50%)
Nikkei 225 16,569.27 +92.43 (0.56%)
Hang Seng Index 21,891.37 -282.97 (-1.28%)
TSEC 8,984.41 -92.23 (-1.02%)
FTSE 100 6,724.43 +3.37 (0.05%)
EURO STOXX 50 2,990.76 +24.66 (0.83%)
CAC 40 4,439.81 +19.23 (0.44%)
S&P TSX 14,555.36 +3.72 (0.03%)
S&P/ASX 200 5,562.40 +5.80 (0.10%)
BSE Sensex 28,051.86 -156.76 (-0.56%)
TA25 1,452.07 -6.51 (-0.45%)
SMI 8,127.20 +32.13 (0.40%)
ATX 2,233.44 +5.28 (0.24%)
IBOVESPA 57,117.26 +450.14 (0.79%)
SET 1,524.07 -0.51 (-0.03%)
BIST100 75,405.53 +161.47 (0.21%)
IBEX 8,587.20 +108.00 (1.27%)
WIG 46,171.72 -547.26 (-1.17%)
TASI 6,335.59 -95.99 (-1.49%)
MERVAL 14,958.92 +116.53 (0.79%)
IPC 46,560.79 -273.08 (-0.58%)
IDX Composite 5,215.99 -83.22 (-1.57%)

Currencies

EUR/USD 1.1168 +0.0084 (0.76%)
USD/JPY 102.1540 -2.6340 (-2.51%)
GBP/USD 1.3256 +0.0095 (0.72%)
USD/CAD 1.3045 -0.0108 (-0.82%)
USD/HKD 7.7589 +0.0026 (0.03%)
USD/CNY 6.6371 -0.0198 (-0.30%)
AUD/USD 0.7599 +0.0089 (1.18%)

Bonds

3 Month 0.23% +0.01 (4.55%)
6 Month 0.35% -0.01 (-2.78%)
2 Year 0.67% -0.02 (-2.90%)
5 Year 1.04% -0.02 (-1.89%)
10 Year 1.47% -0.02 (-1.34%)
30 Year 2.21% -0.02 (-0.90%)
U.S. Economy Grew Less-Than-Forecast 1.2% in Second Quarter
The U.S. economy expanded less than forecast in the second quarter after a weaker start to the year than previously estimated as companies slimmed down inventories and remained wary of investing amid shaky global demand.
Spring slump: U.S. economy only grows 1.2%  
Economists React to Second-Quarter Growth: 'Very Weak'  
Market Chart
18,456.70 +0.35 (0.00%)
2,176.10 +6.04 (0.28%)
5,174.27 +19.29 (0.37%)

Top stories

Exxon Mobil Corp. and Chevron Corp. missed profit and production estimates as wildfires, writedowns and weak refining margins battered oil explorers already reeling under a glut-driven price collapse.
The third time isn't the charm. Or the fourth. Or the fifth. Or, apparently, the sixth or seventh. Earlier this month, the U.S.
Seres Therapeutics Inc. shares lost three quarters of their value Friday after the biotechnology company said its lead experimental drug failed in a clinical trial testing it against hard-to-treat intestinal infections.
Just two years ago, the sole story of Amazon's second quarter would have been the nearly $900 million in profit that it generated.
Analysts were cautiously optimistic, emphasis on the caution, Friday morning after Alphabet delivered a big earnings beat. There were plenty of reasons for optimism, as Alphabet beat earnings expectations on the strength of Google's ad business ...

Trends

Popular searches on GoogleChange Mkt Cap
FRO Frontline Ltd. 1.91% 10.55B

Sector summary

Sector Change % down / up
Energy +0.39%
Basic Materials +0.02%
Industrials +0.08%
Cyclical Cons. Goods ... +0.16%
Non-Cyclical Cons. Goods... +1.17%
Financials +0.65%
Healthcare +0.53%
Technology +0.57%
Telecommunications Servi... +0.77%
Utilities +0.75%